Home>Publications>Risk of drug-induced liver injury in a commercially-insured population of patients with type 2 diabetes mellitus
Esposito DB, Zhao Y, Fusco G, Holick CN, Nkhoma E, Marcinak J, Shah T, Joseph G, Mines D. Risk of drug-induced liver injury in a commercially-insured population of patients with type 2 diabetes mellitus. Poster presented at the 2012 Annual Meeting of the American College of Gastroenterology; October 2012. Las Vegas, NV.
Abstract not available at this time.
RTI Health Solutions®
The power of knowledge. The value of understanding.
Steeped in a tradition of rigor and process, we maintain a legacy of setting the scientific standards within our industry. We employ the right approaches and proven research practices to analyze evidence and draw meaningful insights. Our uncompromisingly ethical and objective researchers ensure that results will hold up to scrutiny and reveal the benefits, risks, value and potential of your products. Learn more.